These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30297329)

  • 1. Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus.
    Barsalou J; Costedoat-Chalumeau N; Berhanu A; Fors-Nieves C; Shah U; Brown P; Laskin CA; Morel N; Levesque K; Buyon JP; Silverman ED; Izmirly PM
    Ann Rheum Dis; 2018 Dec; 77(12):1742-1749. PubMed ID: 30297329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.
    Izmirly PM; Kim MY; Llanos C; Le PU; Guerra MM; Askanase AD; Salmon JE; Buyon JP
    Ann Rheum Dis; 2010 Oct; 69(10):1827-30. PubMed ID: 20447951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.
    Izmirly PM; Costedoat-Chalumeau N; Pisoni CN; Khamashta MA; Kim MY; Saxena A; Friedman D; Llanos C; Piette JC; Buyon JP
    Circulation; 2012 Jul; 126(1):76-82. PubMed ID: 22626746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
    Buchanan NM; Toubi E; Khamashta MA; Lima F; Kerslake S; Hughes GR
    Ann Rheum Dis; 1996 Jul; 55(7):486-8. PubMed ID: 8774170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine Levels throughout Pregnancies Complicated by Rheumatic Disease: Implications for Maternal and Neonatal Outcomes.
    Balevic SJ; Cohen-Wolkowiez M; Eudy AM; Green TP; Schanberg LE; Clowse MEB
    J Rheumatol; 2019 Jan; 46(1):57-63. PubMed ID: 30275257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis.
    Duan J; Ma D; Wen X; Guo Q; Gao J; Zhang G; Xu K; Zhang L
    Lupus; 2021 Jun; 30(7):1163-1174. PubMed ID: 33853420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
    Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
    Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.
    Luo Y; Zhang L; Fei Y; Li Y; Hao D; Liu Y; Zhao Y
    Clin Rheumatol; 2015 Oct; 34(10):1721-8. PubMed ID: 26384980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study.
    Barsalou J; Jaeggi E; Laskin CA; Brown P; Tian SY; Hamilton RM; Silverman ED
    Rheumatology (Oxford); 2017 Sep; 56(9):1552-1559. PubMed ID: 28595349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis.
    Guillotin V; Bouhet A; Barnetche T; Richez C; Truchetet ME; Seneschal J; Duffau P; Lazaro E;
    Joint Bone Spine; 2018 Dec; 85(6):663-668. PubMed ID: 29631068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
    Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
    Front Immunol; 2021; 12():631869. PubMed ID: 33868251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.
    Seo MR; Chae J; Kim YM; Cha HS; Choi SJ; Oh S; Roh CR
    Lupus; 2019 May; 28(6):722-730. PubMed ID: 30971164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study.
    Leroux M; Desveaux C; Parcevaux M; Julliac B; Gouyon JB; Dallay D; Pellegrin JL; Boukerrou M; Blanco P; Lazaro E
    Lupus; 2015 Nov; 24(13):1384-91. PubMed ID: 26082465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal lupus erythematosus].
    Yokogawa N; Sumitomo N; Miura M; Shibuya K; Nagai H; Goto M; Murashima A
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):124-130. PubMed ID: 28603203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies?
    Do SC; Rizk NM; Druzin ML; Simard JF
    Am J Perinatol; 2020 Jul; 37(9):873-880. PubMed ID: 31899930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of hydroxychloroquine in pregnancy and its effect on perinatal outcomes in a population with autoimmune abnormalities.
    Ye S; Zhao X; Liu Y; Ma Y; Wang Y; Zhao J
    Clin Rheumatol; 2023 Apr; 42(4):1137-1150. PubMed ID: 36507975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
    Hosokawa Y; Oiwa H
    Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.